References
- DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.
- Sánchez-Moreno P, Boulaiz H, Ortega-Vinuesa JL, et al. Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells. Int J Mol Sci. 2012;13:4906–4919.
- Jeetah R, Bhaw-Luximon A, Jhurry D. Polymeric nanomicelles for sustained delivery of anti-cancer drugs. Mutat Res. 2014;768:47.
- Cortes J, Pazdur R. Docetaxel. J Clin Oncol. 1995;13:2643–2655.
- Chevallier B, Fumoleau P, Kerbrat P, et al. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol. 1995;13:314–322.
- Gueritte-Voegelein F, Guenard D, Lavelle F, et al. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991;34:992–998.
- Qin Y, Li H, Guo X, et al. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis. PLoS One. 2011;6:e26946.
- Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: a review. Anti-Cancer Drugs. 2007;18:95–103.
- Ganju A, Yallapu MM, Khan S, et al. Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Update. 2014;17:13–23.
- Hobbs S, Monsky W, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA. 1998;95:4607–4612.
- Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
- Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm. 2013;453:198–214.
- Wang Y, Zhao H, Peng J, et al. Targeting therapy of neuropilin-1 receptors overexpressed breast cancer by paclitaxel-loaded CK3-conjugated polymeric micelles. J Biomed Nanotechnol. 2016;12:2097–2111.
- Xu Y, Wang C, Ding Y, et al. Nanoparticles with optimal ratiometric co-delivery of docetaxel with gambogic acid for treatment of multidrug-resistant breast cancer. J Biomed Nanotechnol. 2016;12:1774–1781.
- Zhang H, Li R-Y, Lu X, et al. Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution. J Zhejiang Univ Sci B. 2012;13:981–989.
- Tao W, Zeng X, Liu T, et al. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater. 2013;9:8910–8920.
- Huang J, Tao C, Yu Y, et al. Simultaneous targeting of differentiated breast cancer cells and breast cancer stem cells by combination of docetaxel-and sulforaphane-loaded self-assembled poly (D, L-lactide-co-glycolide)/hyaluronic acid block copolymer-based nanoparticles. J Biomed Nanotechnol. 2016;12:1463–1477.
- Mikhail A, Eetezadi S, Allen C, et al. Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®. PLoS One. 2013;8:e62630.
- Tan L, Peng J, Zhao Q, et al. A novel MPEG-PDLLA-PLL copolymer for docetaxel delivery in breast cancer therapy. Theranostics. 2017;7:2652.
- Li W, Peng J, Tan L, et al. Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 co-loaded micelles. Biomaterials. 2016;106:119–133.
- Shimoda K, Kubota N. Chemo-enzymatic synthesis of ester-linked docetaxel-monosaccharide conjugates as water-soluble prodrugs. Molecules. 2011;16:6769–6777.
- Wang L, Zhang M, Zhang N, et al. Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes. Int J Nanomedicine. 2011;6:e52.
- Jones M-C, Leroux J-C. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999; 9/1/48:101–111.
- Kolahdoozan M, Mirsafaei R, Mallakpour S. Synthesis and properties of new highly soluble poly (amide-ester-imide) s containing poly (ethylene glycol) as a soft segment. Polym Bull. 2012;68:1239–1254.
- Shulkin A, Stöver HD. Polymer microcapsules by interfacial polyaddition between styrene–maleic anhydride copolymers and amines. J Memb Sci. 2002;209:421–432.
- Larsona N, Greisha K, Bauera H, et al. Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin. Int J Pharm. 2011;420:111–117.
- Angelova N, Yordanov G. Nanoparticles of poly (styrene-co-maleic acid) as colloidal carriers for the anticancer drug epirubicin. Colloids Surf A Physicochem Eng Asp. 2014;452:73–81.
- Varshosaz J, Taymouri S, Hassanzadeh F, et al. Self-assembly micelles with lipid core of cholesterol for docetaxel delivery to B16F10 melanoma and HepG2 cells. J Liposome Res. 2015;25:157–165.
- Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm. 2007;65:259–269.
- Kim SY, Shin IG, Lee YM, et al. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J Control Release. 1998;51:13–22.
- Tong S-W, Xiang B, Dong D-W, et al. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int J Pharm. 2012;434:413–419.
- Cui Y, Zhang M, Zeng F, et al. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces. 2016;8:32159–32169.
- Yang ZL, X, Zhang X, Liu J, et al. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles. Biomed Mater. 2013;8:025012.
- Zhang L, Tan L, Chen L, et al. A simple method to improve the stability of docetaxel micelles. Sci Rep. 2016;6:36957.
- Tan L, Ma B, Chen L, et al. Toxicity evaluation and anti-tumor study of docetaxel loaded mpeg-polyester micelles for breast cancer therapy. J Biomed Nanotechnol. 2017;13:393–408.
- Wang X, Li J, Wang Y, et al. HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano. 2009;3:3165–3174.
- Chibowski S, Paszkiewicz M. Influence of the molecular weight of polyethylene glycol and polyethylene oxide on the adsorption and electrochemical properties of the titania/electrolyte solution interface. Adsorpt Sci Technol. 1999;17:845–855.
- Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64:261–268.
- Stiufiuc R, Iacovita C, Nicoara R, et al. One-step synthesis of PEGylated gold nanoparticles with tunable surface charge. J Nanomater. 2013;2013:88.
- Gaucher G, Marchessault RH, Leroux J-C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release. 2010;4/2/143:2–12.
- Iyer AK, Greish K, Fang J, et al. High-loading nanosized micelles of copoly (styrene–maleic acid)–zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor. Biomaterials 2007;28:1871–1881.
- Siepmann J, Faisant N, Akiki J, et al. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release. 2004;96:123–134.
- Sun B, Ranganathan B, Feng S-S. Multifunctional poly (D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008;29:475–486.